Sonendo Analyst Ratings
Maintaining Hold: Sonendo Struggles With Revenue Shortfalls and Uncertain Outlook
Goldman Sachs Maintains Buy on Sonendo, Lowers Price Target to $1.5
Sonendo Analyst Ratings
Sonendo Maintains Buy Rating Despite Revised FY23 Guide: Potential Growth With CleanFlow Launch and GentleWave Expansion
Piper Sandler Maintains Neutral on Sonendo, Lowers Price Target to $0.4-Report Released on 8th Nov 2023
Morgan Stanley Maintains Equal-Weight on Sonendo, Lowers Price Target to $4.6
Sonendo Analyst Ratings
Stifel Nicolaus Sticks to Its Buy Rating for Sonendo (SONX)
Stifel Maintains Buy on Sonendo, Lowers Price Target to $1
Sonendo Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: Sonendo (SONX), Rani Therapeutics Holdings (RANI)
Piper Sandler Reaffirms Their Hold Rating on Sonendo (SONX)
Goldman Sachs Maintains Buy on Sonendo, Lowers Price Target to $1.75
Sonendo Analyst Ratings
Goldman Sachs Adjusts Price Target on Sonendo to $1.75 From $2, Maintains Buy Rating
Piper Sandler Downgrades Sonendo to Neutral, Lowers Price Target to $1
Sonendo Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Decibel Therapeutics (DBTX), Galera Therapeutics (GRTX) and Sonendo (SONX)
Analyst Ratings for Sonendo